Basics Day One Biopharmaceuticals, Inc. IPO Date: May 27, 2021 Sector: Healthcare Industry: Biotech Market Cap: $813.19M Activated in VL: True Average Daily Range Avg Daily Range: $0.42 | 2.83% Avg Daily Range (30 D): $0.25 | 3.00% Avg Daily Range (90 D): $0.20 | 2.63% Institutional Daily Volume Avg Daily Volume: .76M Avg Daily Volume (30 D): 2.42M Avg Daily Volume (90 D): 1.69M Trade Size Avg Trade Size (Sh.): 86 Avg Trade Size (Sh.) (30 D): 102 Avg Trade Size (Sh.) (90 D): 101 Institutional Trades Total Inst.Trades: 1,622 Avg Inst. Trade: $1.56M Avg Inst. Trade (30 D): $1.78M Avg Inst. Trade (90 D): $1.26M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.8M Avg Closing Trade (30 D): $1.9M Avg Closing Trade (90 D): $1.32M Avg Closing Volume: 138.68K     News Nov 13, 2025 @ 3:15 PM Day One Biopharma Expands Oncology Pipeline With $... Source: Vandana Singh Nov 13, 2025 @ 11:00 AM Day One to Acquire Mersana Therapeutics to Advance... Source: Day One Biopharmaceuticals Aug 5, 2025 @ 8:00 PM Day One Reports Second Quarter 2025 Financial Resu... Source: Day One Biopharmaceuticals Oct 22, 2024 @ 6:33 PM Global Cancer Antibody Drug Conjugates Market Size... Source: Kuick Research Jun 19, 2024 @ 2:29 PM Day One (DAWN) In-Licenses MabCare Cancer Candidat... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.52 $-.19 $-.29 Diluted EPS $-1.52 $-.19 $-.29 Revenue $ 133.67M $ 39.8M $ 33.91M Gross Profit $ $ $ Net Income / Loss $ -72.79M $ M $ -30.32M Operating Income / Loss $ -165.62M $ -24.25M $ -34.97M Cost of Revenue $ $ $ Net Cash Flow $ -379.49M $ 7.66M $ -89.35M PE Ratio